Prolonged Tamoxifen Surpasses Oophorectomy in Breast Cancer Prolonged Tamoxifen Surpasses Oophorectomy in Breast Cancer

For premenopausal women with estrogen receptor-positive breast cancer treated for 5 years with tamoxifen, lifetime outcomes are best with an extra 5 years of tamoxifen, a simulation model predicts.Medscape Medical News

Source: Medscape Medical News Headlines - May 9, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news